Return Peptide Library
Vosoritide
BLevel 1 evidenceVosoritide
Natriuretic peptides
Basic Information
Categories
C-type natriuretic peptide analog
Overview
Modified C-type natriuretic peptide analog approved by the FDA for children with achondroplasia.
Efficacy Rating
FDA-approved, rare disease, pediatric
Evidence Level
Grade B
Evidence Type
No data available
Confidence
No data available
China Regulatory Status
Cosmetic Ingredient Directory
No data available
Food/Supplements
No data available
Medicine
No data available
Similar Peptide Recommendations
BNP
BNP
BNatriuretic peptides
endogenous, cardiac, biomarker
C-Type Natriuretic Peptide
C-Type Natriuretic Peptide
BNatriuretic peptides
endogenous, natriuretic peptide, endothelium
ANP
ANP
CNatriuretic peptides
Endocardial, cardiac, natriuretic peptide
Nesiritide
Nesiritide
CNatriuretic peptides
FDA-approved, cardiology, recombinant
Disclaimer
The content on this platform is for educational and informational purposes only and does not constitute medical advice, formulation guidance, or a guarantee of regulatory compliance. All efficacy claims are labeled with their evidence level; please consult a professional before making any decisions.